Sage Journals: Discover world-class research

1-10 of 1113 results for dose-limiting toxicity

Sort by:

Relevance

Select allExport selected citations

Sort by:

Relevance

Retricted access

Research article

First published 2020-7

Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib

Nazım C Demircan, Özkan Alan, Tuğba Başoğlu Tüylü [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2016-4

A Phase I/II trial design when response is unobserved in subjects with dose-limiting toxicity

Thomas M Braun, Shan Kang, Jeremy MG Taylor

Statistical Methods in Medical Research

Retricted access

Research article

First published 2018-8

Modeling adverse event counts in phase I clinical trials of a cytotoxic agent

Daniel G Muenz, Thomas M Braun, Jeremy MG Taylor

Clinical Trials

Retricted access

Research article

First published 2024-4

Reporting and impact of subsequent cycle toxicities in oncology phase I clinical trials

Avina Rami, Steven G DuBois, Kevin Campbell

Clinical Trials

Open access

Research article

First published 2021

Tolerance and Pharmacokinetics of Recombinant Human Endostatin Administered as Single-Dose or Multiple-Dose Infusions in Patients With Advanced Solid Tumors: A Phase I Clinical Trial

Xu Wang, Yehui Shi, Yongsheng Jia [...]

Technology in Cancer Research & Treatment

Retricted access

Research article

First published 2023-4

The physical exam’s role in determining dose-limiting toxicity prior to immunochemotherapy administration in lymphoma

John S. Runge, Anna B. Brown, Tycel J. Phillips [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2021-2

Phase I study of intraperitoneal bevacizumab for treating refractory malignant ascites

Furong Kou, Jifang Gong, Yan Li [...]

Journal of International Medical Research

Retricted access

Research article

First published 2007-3

EWOC 2.0: Interactive Software for Dose Escalation in Cancer Phase I Clinical Trials

Zhiheng Xu, Mourad Tighiouart, André Rogatko

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2021-6

A Bayesian dose-finding design for outcomes evaluated with uncertainty

Matthew J Schipper, Ying Yuan, Jeremy MG Taylor [...]

Clinical Trials

Retricted access

Research article

First published 2015-12

A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D 2 ) in patients with advanced cancer

Kari B Wisinski, Wendy M Ledesma, Jill Kolesar [...]

Journal of Oncology Pharmacy Practice

Search results